Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
High	O
fevers	O
and	O
worsening	O
renal	O
function	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
DM1,	O
recurrent	O
UTIs,	B-Urinary_tract_infection
ESRD	O
s/p	O
DDRT	O
in	O
___	O
on	O
tacrolimus	O
who	O
is	O
transferred	O
from	O
an	O
OSH	O
for	O
high	O
fevers	O
and	O
worsening	O
renal	O
function,	O
found	O
to	O
have	O
influenza	O
and	O
potential	O
infected	O
transplant.	O
The	O
patient	O
was	O
initially	O
sent	O
from	O
his	O
nursing	B-Lives_in_carehome
home	B-Lives_in_carehome
(Epoch	O
of	O
___	O
for	O
a	O
general	O
decline	O
in	O
condition	O
including	O
worsening	O
shortness	O
of	O
breath,	O
temperature,	O
lethargy,	O
dyspnea	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Reportedly,	O
he	O
was	O
alert	O
and	O
oriented	B-Delirium
x3	B-Delirium
before	O
being	O
seen	O
in	O
the	O
hospital.	O
Prior	O
to	O
transfer,	O
he	O
had	O
a	O
CXR	O
which	O
reportedly	O
showed	O
pulmonary	O
congestion.	O
Treated	O
with	O
40mg	O
IV	O
lasix.	O
He	O
was	O
brought	O
to	O
___	O
where	O
he	O
was	O
noted	O
to	O
have	O
a	O
creatinine	O
of	O
4.28	O
and	O
potassium	O
of	O
5.9.	O
He	O
was	O
given	O
insulin	O
and	O
dextrose.	O
Influenza	O
was	O
positive	O
and	O
the	O
patient	O
was	O
started	O
on	O
Tamiflu.	O
Here	O
the	O
patient	O
is	O
only	O
able	O
to	O
provide	O
limited	O
information.	O
At	O
baseline	O
he	O
is	O
reported	O
alert,	O
oriented.	B-Delirium
not	O
usually	O
with	O
catheter.	O
In	O
the	O
ED,	O
initial	O
vital	O
signs	O
were:	O
102.8	O
78	O
183/47	O
21	O
99%	O
RA	O
Labs	O
were	O
notable	O
for	O
hyperkalemia,	O
anemia,	O
Glucose	O
UreaN	O
Creat	O
Na	O
K	O
Cl	O
HCO3	O
AnGap	O
204	O
93*	O
4.5*	O
148*	O
5.8*	O
122*	O
15*	O
17	O
WBC	O
RBC	O
Hgb	O
Hct	O
Plt	O
5.7	O
2.65	O
8.5	O
27.3	O
106	O
Patient	O
was	O
admitted	O
to	O
___	O
2	O
and	O
is	O
transferred	O
to	O
the	O
MICU	O
for	O
hyperkalemia,	O
hyperglycemia,	O
acidosis,	O
renal	O
failure.	O
Past	O
Medical	O
History:	O
PAST	O
MEDICAL	O
HISTORY:	O
Type	O
1	O
diabetes	O
Triopathy	O
secondary	O
to	O
agent	O
orange	O
HTN	O
End-stage	O
renal	O
disease	O
status	O
post	O
cadaveric	O
renal	O
transplant	O
in	O
___	O
History	O
of	O
recurrent	O
UTIs	B-Lower_respiratory_tract_infection
Right	O
BKA	O
and	O
___	O
left	O
BKA	O
in	O
___,	O
right	O
BKA	O
revision	O
in	O
___	O
with	O
AKA.	O
Left	O
AKA	O
___	O
Possible	O
stricture	O
or	O
stenosis	O
of	O
the	O
proximal	O
central	O
veins	O
-	O
very	O
difficult	O
IJ	O
or	O
subclavian	O
access	O
in	O
the	O
past	O
PAST	O
SURGICAL	O
HISTORY:	O
1.	O
Open	O
reduction	O
and	O
internal	O
fixation	O
left	O
hip	O
___.	O
2.	O
AV	O
fistula	O
with	O
revision	O
both	O
arms.	O
3.	O
Laparoscopic	O
lysis	O
of	O
adhesions.	O
4.	O
Cataract	B-Visual_impairment
extraction	O
and	O
intraocular	O
lens	O
O.U.	O
5.	O
Penile	O
implant.	O
6.	O
Cadaveric	O
renal	O
transplant	O
___,	O
by	O
Dr.	O
___	O
at	O
___.	O
7.	O
Renal	O
biopsy	O
___.	O
8.	O
Bilateral	O
below	O
the	O
knee	O
amputations	O
___,	O
at	O
outside	O
hospital.	O
9.	O
Revision	O
of	O
right	O
below	O
the	O
knee	O
amputation	O
on	O
___,	O
by	O
Dr.	O
___.	O
L	O
AKA	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Brother	O
with	O
diabetes	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
Vitals-	O
T:	O
BP:182/61	O
P:	O
93	O
R:	O
24	O
18	O
O2:	O
98%	O
GENERAL:	O
PAtient	O
appears	O
uncomfortable,	O
laying	O
in	O
bed.	O
HEENT:	O
Sclera	O
anicteric,	O
very	O
dry	O
mucous	O
membranes,	O
oropharynx	O
clear,	O
pupils	O
1mm	O
b/l	O
NECK:	O
supple,	O
JVP	O
not	O
elevated	O
LUNGS:	O
Coarse	O
breath	O
sounds	O
anteriorly	O
tachypnic	O
breathing	O
with	O
accessory	O
muscle	O
use	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
ABD:	O
soft,	O
non-tender,	O
bowel	O
sounds	O
present,	O
has	O
periumbilical	O
subcutaneous	O
bulb,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
Neuro:	O
AO	B-Unspecified_cognitive_impairment
x1	B-Unspecified_cognitive_impairment
(knows	O
hes	O
in	O
the	O
hospital)	O
moves	O
upper	O
extremitites	O
spontaneously,	O
will	O
not	O
follow	O
instruction	O
to	O
test	O
cranial	O
nerves	O
EXT:	O
b/l	O
AKA,	O
no	O
edema	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
Vitals:	O
T	O
98.3	O
(99.4)	O
BP	O
111/42	O
(111/42-150/50)	O
HR	O
69	O
(69-74)	O
RR	O
20	O
O2	O
97%RA	O
Pain	O
___	O
GENERAL:	O
Alert,	O
oriented	B-Delirium
(to	O
year	O
and	O
___	O
"hospital")	O
LUNGS:	O
diffuse	O
anterior	O
rhonchorous	O
sounds,	O
likely	O
referred	O
from	O
upper	O
airway	O
CV:	O
RRR,	O
no	O
M/R/G	O
ABD:	O
soft,	O
non-tender	O
EXT:	O
b/l	O
AKA,	O
palpable	O
calcified	O
cords	O
in	O
both	O
arms	O
GU:	O
Severe	O
hypospadius	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
==============	O
___	O
07:15AM	O
BLOOD	O
WBC-5.7	O
RBC-2.65*	O
Hgb-8.5*	O
Hct-27.3*	O
MCV-103*#	O
MCH-32.2*#	O
MCHC-31.3	O
RDW-21.2*	O
Plt	O
___	O
___	O
07:15AM	O
BLOOD	O
Neuts-84.4*	O
Lymphs-9.0*	O
Monos-5.9	O
Eos-0.6	O
Baso-0	O
___	O
07:15AM	O
BLOOD	O
___	O
PTT-33.7	O
___	O
___	O
07:15AM	O
BLOOD	O
Glucose-204*	O
UreaN-93*	O
Creat-4.5*#	O
Na-148*	O
K-5.8*	O
Cl-122*	O
HCO3-15*	O
AnGap-17	O
___	O
07:15AM	O
BLOOD	O
ALT-10	O
AST-21	O
AlkPhos-65	O
TotBili-0.4	O
___	O
05:20PM	O
BLOOD	O
Albumin-3.2*	O
Calcium-8.5	O
Phos-5.0*#	O
Mg-2.3	O
___	O
11:54AM	O
BLOOD	O
___	O
pO2-48*	O
pCO2-30*	O
pH-7.29*	O
calTCO2-15*	O
Base	O
XS--10	O
Intubat-NOT	O
INTUBA	O
___	O
07:17AM	O
BLOOD	O
Lactate-1.2	O
___	O
08:10AM	O
URINE	O
Color-Yellow	O
Appear-Hazy	O
Sp	O
___	O
___	O
08:10AM	O
URINE	O
Blood-TR	O
Nitrite-NEG	O
Protein-100	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-LG	O
___	O
08:10AM	O
URINE	O
RBC-6*	O
WBC->182*	O
Bacteri-FEW	O
Yeast-OCC	O
Epi-0	O
___	O
08:10AM	O
URINE	O
Osmolal-417	O
NOTABLE	O
LABS	O
============	O
___	O
05:20PM	O
BLOOD	O
tacroFK-LESS	O
THAN	O
___	O
04:39AM	O
BLOOD	O
tacroFK-LESS	O
THAN	O
___	O
07:50AM	O
BLOOD	O
tacroFK-9.2	O
___	O
08:30AM	O
BLOOD	O
tacroFK-14.0	O
___	O
07:30AM	O
BLOOD	O
tacroFK-11.5	O
___	O
06:55AM	O
BLOOD	O
tacroFK-5.3	O
___	O
07:05AM	O
BLOOD	O
tacroFK-5.7	O
___	O
11:00AM	O
BLOOD	O
tacroFK-6.0	O
___	O
06:45AM	O
BLOOD	O
tacroFK-11.9	O
___	O
07:05AM	O
BLOOD	O
tacroFK-6.7	O
___	O
06:50AM	O
BLOOD	O
tacroFK-7.0	O
___	O
06:45AM	O
BLOOD	O
tacroFK-5.6	O
___	O
07:09AM	O
BLOOD	O
tacroFK-6.7	O
___	O
04:47AM	O
BLOOD	O
Lactate-1.6	O
___	O
08:30AM	O
BLOOD	O
Ret	O
Man-0.8	O
___	O
08:30AM	O
BLOOD	O
Hapto-203*	O
___	O
04:39AM	O
BLOOD	O
calTIBC-88*	O
Ferritn-318	O
TRF-68*	O
___	O
11:22PM	O
BLOOD	O
calTIBC-100*	O
Ferritn-316	O
TRF-77*	O
___	O
06:45AM	O
BLOOD	O
Cortsol-6.3	O
___	O
11:54AM	O
BLOOD	O
___	O
pO2-48*	O
pCO2-30*	O
pH-7.29*	O
calTCO2-15*	O
Base	O
XS--10	O
Intubat-NOT	O
INTUBA	O
___	O
07:39PM	O
BLOOD	O
___	O
pO2-192*	O
pCO2-21*	O
pH-7.22*	O
calTCO2-9*	O
Base	O
XS--17	O
___	O
08:21PM	O
BLOOD	O
___	O
pO2-142*	O
pCO2-23*	O
pH-7.27*	O
calTCO2-11*	O
Base	O
XS--14	O
Comment-GREEN	O
TOP	O
___	O
11:30PM	O
BLOOD	O
___	O
pO2-141*	O
pCO2-26*	O
pH-7.38	O
calTCO2-16*	O
Base	O
XS--7	O
___	O
01:28AM	O
BLOOD	O
___	O
pO2-156*	O
pCO2-27*	O
pH-7.39	O
calTCO2-17*	O
Base	O
XS--6	O
___	O
04:47AM	O
BLOOD	O
___	O
pO2-126*	O
pCO2-30*	O
pH-7.42	O
calTCO2-20*	O
Base	O
XS--3	O
MICROBIOLOGY	O
============	O
___	O
8:10	O
am	O
URINE	O
URINE	O
CULTURE	O
(Final	O
___:	O
YEAST.	O
10,000-100,000	O
ORGANISMS/ML.	O
Time	O
Taken	O
Not	O
Noted	O
Log-In	O
Date/Time:	O
___	O
9:15	O
am	O
URINE	O
VIRAL	O
CULTURE	O
(Preliminary):	O
NO	O
VIRUS	O
ISOLATED.	O
___	O
12:08	O
pm	O
URINE	O
Source:	O
Catheter.	O
URINE	O
CULTURE	O
(Preliminary):	O
___	O
ALBICANS,	O
PRESUMPTIVE	O
IDENTIFICATION.	O
>100,000	O
ORGANISMS/ML.	O
___	O
7:30	O
am	O
Immunology	O
(CMV)	O
CMV	O
Viral	O
Load	O
(Final	O
___:	O
CMV	O
DNA	O
detected,	O
less	O
than	O
137	O
IU/mL.	O
Performed	O
by	O
Cobas	O
Ampliprep	O
/	O
Cobas	O
Taqman	O
CMV	O
Test.	O
Linear	O
range	O
of	O
quantification:	O
137	O
IU/mL	O
-	O
9,100,000	O
IU/mL.	O
Limit	O
of	O
detection	O
91	O
IU/mL.	O
___	O
07:30	O
EBV	O
PCR,	O
QUANTITATIVE,	O
WHOLE	O
BLOOD	O
Test	O
Result	O
Reference	O
Range/Units	O
SOURCE	O
Whole	O
Blood	O
EBV	O
DNA,	O
QN	O
PCR	O
9994	O
H	O
<200	O
copies/mL	O
___	O
07:30	O
ADENOVIRUS	O
PCR	O
Test	O
Result	O
Reference	O
Range/Units	O
SOURCE	O
Whole	O
Blood	O
ADENOVIRUS	O
DNA,	O
QN	O
PCR	O
<500	O
<500	O
copies/mL	O
IMAGING/STUDIES	O
===============	O
CXR	O
___	O
Bibasilar	O
opacities	O
which	O
may	O
reflect	O
a	O
component	O
of	O
atelectasis	O
though	O
an	O
infectious	O
process	O
cannot	O
be	O
excluded,	O
particularly	O
at	O
the	O
right	O
lung	O
base	O
and	O
right	O
upper	O
lobe	O
.	O
RENAL	O
TRANSPLANT	O
U.S.	O
___	O
1.	O
Gas	O
throughout	O
the	O
renal	O
transplant	O
collecting	O
system	O
suggestive	O
for	O
infection.	O
2.	O
Mild-moderate	O
elevation	O
of	O
the	O
transplant	O
resistive	O
indices.	O
3.	O
4.8	O
cm	O
perinephric	O
fluid	O
collection	O
of	O
unclear	O
etiology	O
with	O
a	O
drain	O
in	O
place.	O
___	O
12:___BD	O
&	O
PELVIS	O
W/O	O
CONTRAST	O
1.	O
Right	O
lower	O
quadrant	O
renal	O
transplant	O
with	O
air	O
in	O
the	O
collecting	O
system	O
and	O
mild	O
hydronephrosis,	O
findings	O
concerning	O
for	O
infection	O
from	O
gas	O
generating	O
bacteria.	O
2.	O
Relatively	O
decompressed	O
bladder	O
with	O
wall	O
thickening,	O
correlate	O
with	O
urinalysis.	O
3.	O
Air	O
within	O
the	O
bladder	O
possibly	O
from	O
instrumentation,	O
but	O
may	O
also	O
be	O
sequela	O
of	O
infection.	O
4.	O
3.3	O
x	O
1.6	O
cm	O
hypodense	O
fluid	O
collection	O
within	O
the	O
superficial	O
tissues	O
of	O
the	O
left	O
lower	O
abdominal	O
wall,	O
of	O
unclear	O
significance,	O
possibly	O
representing	O
a	O
seroma.	O
5.	O
Compression	O
deformity	O
of	O
the	O
L3	O
vertebral	O
body	O
is	O
age	O
indeterminate	O
without	O
prior	O
studies.	O
6.	O
Small	O
bilateral	O
pleural	O
effusion	O
right	O
greater	O
than	O
left.	O
7.	O
Porcelain	O
gallbladder.	O
8.	O
Dense	O
atherosclerotic	O
vascular	O
calcifications.	O
___	O
CT	O
chest	O
IMPRESSION:	O
Evaluation	O
of	O
the	O
lungs	O
is	O
slightly	O
limited	O
due	O
to	O
motion.	O
Within	O
that	O
limitation,	O
patchy	O
ground-glass	O
opacities	O
in	O
the	O
right	O
upper	O
lobe	O
may	O
represent	O
early	O
pneumonia.	B-Lower_respiratory_tract_infection
Large	O
bilateral	O
pleural	O
effusions	O
with	O
adjacent	O
compressive	O
atelectasis.	O
Small	O
to	O
moderate	O
pericardial	O
effusion.	O
No	O
lymphadenopathy	O
in	O
the	O
chest.	O
DISCHARGE	O
LABS	O
==============	O
___	O
06:45AM	O
BLOOD	O
WBC-3.7*	O
RBC-2.53*	O
Hgb-8.0*	O
Hct-25.9*	O
MCV-102*	O
MCH-31.5	O
MCHC-30.8*	O
RDW-19.6*	O
Plt	O
___	O
___	O
07:09AM	O
BLOOD	O
Glucose-76	O
UreaN-67*	O
Creat-3.4*	O
Na-148*	O
K-4.9	O
Cl-118*	O
HCO3-19*	O
AnGap-16	O
___	O
07:09AM	O
BLOOD	O
Calcium-8.6	O
Phos-4.3	O
Mg-2.___	O
year	O
old	O
male	O
with	O
DM1,	O
recurrent	O
UTI,	B-Urinary_tract_infection
s/p	O
DDRT	O
in	O
___	O
on	O
immunosuppression,	O
HTN,	O
HLD	O
who	O
presents	O
with	O
worsening	O
renal	O
function	O
and	O
influenza	O
transferred	O
to	O
the	O
MICU	O
for	O
worsening	O
acidosis,	O
hyperkalemia	O
and	O
hyperglycemia.	O
Patient	O
was	O
transferred	O
to	O
the	O
ICU	O
for	O
treatment	O
of	O
DKA	O
and	O
hyperkalemia.	O
#	O
Hyperkalemia:	O
Likely	O
due	O
to	O
combination	O
___	O
and	O
DKA.	O
Patient	O
recieved	O
insulin	O
and	O
dextrose	O
at	O
OSH	O
and	O
calcium	O
gluconate	O
x2,	O
10U	O
insulin	O
bolus	O
while	O
on	O
the	O
floor.	O
EKG	O
with	O
peaked	O
T	O
waves,	O
QRS	O
complex	O
not	O
widened.	O
Hyperkalemia	O
resolved	O
with	O
insulin	O
drip	O
for	O
DKA	O
(see	O
below)	O
EKG	O
changes	O
resolved	O
and	O
patient	O
was	O
asymptomatic.	O
He	O
was	O
kept	O
on	O
a	O
potassium	O
restricted	O
diet.	O
#	O
Hyperglycemia	O
|	O
#	O
Anion	O
Gap	O
Acidosis	O
|	O
#	O
Type	O
1	O
Diabetes:	O
Likely	O
DKA	O
in	O
a	O
T1DM	O
though	O
no	O
ketones	O
in	O
urine	O
on	O
admission.	O
Lactate	O
normal.	O
Likely	O
in	O
the	O
setting	O
of	O
UTI.	B-Urinary_tract_infection
Received	O
2amps	O
of	O
bicarb	O
for	O
acidosis.	O
In	O
the	O
ICU	O
He	O
was	O
treated	O
with	O
an	O
insulin	O
drip	O
and	O
transitioned	O
to	O
subcutaneous	O
insulin	O
once	O
gap	O
closed.	O
On	O
the	O
floor,	O
his	O
SC	O
insulin	O
was	O
titrated	O
to	O
24U	O
glargine	O
in	O
AM	O
to	O
achieve	O
good	O
glycemic	O
control.	O
He	O
had	O
some	O
episodes	O
of	O
hypoglycemia	O
in	O
the	O
mornings	O
that	O
required	O
subsequent	O
downtitration	O
of	O
his	O
glargine	O
to	O
12U	O
in	O
the	O
AM	O
ultimately.	O
#	O
UTI:	B-Urinary_tract_infection
Patient	O
with	O
reported	O
history	O
of	O
recurrent	O
UTIs	B-Urinary_tract_infection
with	O
malfunctioning	O
penile	O
implant	O
may	O
have	O
element	O
of	O
obstruction.	O
Renal	O
ultrasound	O
with	O
gas	O
in	O
collecting	O
system.	O
Concern	O
for	O
transplant	O
pyelonephritis.	B-Urinary_tract_infection
Patient	O
initially	O
treated	O
with	O
broad	O
spectrum	O
antibiotics.	O
Urine	O
cultures	O
eventually	O
grew	O
out	O
___.	O
In	O
the	O
setting	O
of	O
being	O
immunesuppressed,	O
he	O
was	O
switched	O
to	O
fluconazole	O
for	O
a	O
2	O
week	O
course	O
of	O
treatment.	O
Given	O
patient's	O
goals	O
of	O
care,	O
it	O
was	O
discharged	O
at	O
discharge,	O
2	O
days	O
short	O
of	O
full	O
course.	O
He	O
had	O
a	O
repeat	O
urine	O
culture	O
at	O
discharge	O
to	O
determine	O
if	O
cure	O
was	O
achieved.	O
#	O
Pancytopenia:	O
Patient	O
became	O
pancytopenic	O
during	O
stay	O
without	O
clear	O
etiology,	O
most	O
likely	O
due	O
to	O
his	O
acute	O
viral	O
illness	O
and	O
presentation.	O
Not	O
on	O
any	O
new	O
medications	O
that	O
would	O
be	O
particularly	O
marrow	O
suppression,	O
and	O
off	O
of	O
azathioprine.	O
Reticulocyte	O
count	O
was	O
very	O
low.	O
Patient	O
is	O
on	O
EPO	O
at	O
home.	B-Lives_alone
Iron	O
studies	O
showed	O
normal	O
ferritin,	O
which	O
suggested	O
against	O
iron	O
deficiency.	O
Additional	O
viral	O
work	O
up	O
revealed	O
EBV	O
viremia.	O
CT	O
chest	O
was	O
performed	O
that	O
showed	O
no	O
evidence	O
of	O
PTLD.	O
Given	O
his	O
goals	O
of	O
care,	O
EBV	O
viremia	O
will	O
not	O
be	O
followed	O
up.	O
#	O
___	O
s/p	O
DDRT:	O
Cr	O
bumped	O
3.6	O
to	O
4.5	O
on	O
presentation.	O
Likely	O
from	O
poor	O
oral	O
intake	O
secondary	O
to	O
influenza	O
and	O
osmotic	O
diuresis.	O
With	O
fluid	O
repletion,	O
patient's	O
___	O
resolved.	O
His	O
Cr	O
settled	O
out	O
near	O
his	O
baseline	O
of	O
3.4-3.8.	O
Given	O
pancytopenia,	O
his	O
azathioprine	O
was	O
held	O
and	O
discontinued	O
on	O
discharge.	O
Tacrolimus	O
dose	O
was	O
adjusted	O
given	O
drug	O
interactions	O
with	O
his	O
fluconazole	O
and	O
his	O
+	O
EBV	O
titer.	O
He	O
was	O
discharged	O
on	O
his	O
prior	O
home	O
stable	O
dose.	O
#	O
Influenza:	O
flu	O
positive	O
at	O
OSH.	O
Completed	O
5	O
day	O
course	O
of	O
oseltamivir.	O
#	O
Urinary	O
Retention	O
|	O
#	O
Penile	O
Implant:	O
Foley	O
placed	O
by	O
Urology.	O
Patient	O
subsequently	O
failed	O
voiding	O
trial.	O
Intermittent	O
straight	O
catheterization	O
was	O
performed	O
given	O
desire	O
to	O
best	O
treat	O
___	O
UTI.	B-Urinary_tract_infection
Patient's	O
penile	O
implant	O
was	O
also	O
noted	O
to	O
be	O
stuck	O
in	O
the	O
erect	O
position.	O
He	O
will	O
need	O
follow	O
up	O
after	O
discharge	O
with	O
Urology	O
for	O
long	O
term	O
management	O
of	O
urinary	O
drainage.	O
He	O
was	O
straight	O
cathed	O
after	O
he	O
was	O
determined	O
to	O
have	O
the	O
___	O
UTI,	B-Urinary_tract_infection
but	O
as	O
the	O
patient's	O
wife	O
was	O
unable	O
to	O
manage	O
straight	O
cathing	O
the	O
patient	O
at	O
home,	B-Lives_alone
a	O
foley	O
was	O
re-inserted	O
prior	O
to	O
discharge.	O
#	O
Hypertension:	O
HTN	O
to	O
190s	O
on	O
admission.	O
The	O
patient	O
continued	O
home	O
hydralazine,	O
amlodipine,	O
and	O
doxazosin	O
but	O
was	O
still	O
hypertensive	O
to	O
SBP	O
180s.	O
He	O
was	O
started	O
on	O
labetalol	O
200	O
mg	O
BID.	O
Home	O
metoprolol	O
was	O
discontinued	O
as	O
there	O
was	O
no	O
clear	O
indication	O
for	O
it,	O
and	O
his	O
heart	O
rate	O
was	O
persistently	O
in	O
the	O
___.	O
#	O
AMS:	B-Delirium
Reportedly,	O
patient	O
has	O
had	O
slow	O
decline	O
over	O
the	O
last	O
six	O
months	O
but	O
is	O
"alert	O
and	O
oriented"	B-Delirium
at	O
baseline.	O
Initially	O
quite	O
delirious	O
in	O
the	O
ICU.	O
On	O
the	O
floor,	O
patient	O
intermittently	O
became	O
confused	B-Delirium
and	O
alert,	O
which	O
was	O
corroborated	O
as	O
baseline	O
by	O
wife.	O
#	O
Goals	O
of	O
Care	O
Discussion:	O
The	O
patient	O
was	O
initially	O
planned	O
to	O
be	O
discharged	O
to	O
rehab	O
with	O
likely	O
gradual	O
transition	O
to	O
palliative/hospice	O
care,	O
but	O
his	O
Medicare	O
days	O
ran	O
out,	O
so	O
he	O
could	O
not	O
go	O
to	O
rehab.	O
Per	O
discussion	O
with	O
his	O
wife,	O
plan	O
was	O
to	O
discharge	O
with	O
hospice	O
care.	O
He	O
will	O
still	O
receive	O
his	O
necessary	O
medications	O
(such	O
as	O
tacrolimus)	O
and	O
will	O
receive	O
follow-up	O
appointments	O
with	O
his	O
specialists.	O
His	O
wife	O
may	O
make	O
the	O
decision	O
to	O
bring	O
him	O
back	O
to	O
the	O
hospital	O
if	O
she	O
feels	O
he	O
is	O
looking	O
worse.	O
His	O
diet	O
will	O
be	O
a	O
potassium-restricted,	O
ground,	O
thin	O
liquids	O
diet-	O
although	O
he	O
aspirates	O
thin	O
liquids,	O
it	O
will	O
improve	O
his	O
comfort	O
and	O
his	O
family	O
knows	O
the	O
risks.	O
Dialysis	O
is	O
not	O
within	O
his	O
goals	O
of	O
care.	O
He	O
will	O
obtain	O
home	B-Lives_alone
services	O
for	O
blood	O
draws	O
and	O
will	O
need	O
a	O
___	O
lift;	O
they	O
already	O
have	O
a	O
hospital	O
bed	O
at	O
home.	B-Lives_alone
#	O
Communication:	O
wife,	O
___,	O
___	O
#	O
Code:	O
DNR/DNI	O
(Confirmed	O
with	O
___,	O
wife	O
and	O
HCP,	O
over	O
the	O
phone	O
during	O
this	O
hospitalization)	O
TRANSITIONAL	O
ISSUES	O
-	O
Please	O
see	O
medication	O
list	O
for	O
changes	O
during	O
hospital	O
stay.	O
-	O
Prior	O
to	O
discharge,	O
a	O
foley	O
was	O
placed	O
and	O
a	O
urine	O
culture	O
was	O
drawn.	O
Will	O
follow	O
up	O
to	O
determine	O
whether	O
he	O
needs	O
additional	O
fluconazole.	O
-	O
Azithioprine	O
was	O
held	O
during	O
admission	O
due	O
to	O
leukopenia,	O
will	O
continue	O
to	O
hold	O
at	O
discharge.	O
-	O
No	O
need	O
to	O
f/u	O
EBV	O
titer	O
-	O
Scheduled	O
for	O
Urology	O
follow	O
up	O
to	O
discuss	O
long-term	O
management	O
of	O
his	O
urinary	O
retention	O
and	O
whether	O
there	O
are	O
better	O
options	O
than	O
a	O
foley.	O
-	O
Please	O
continue	O
to	O
check	O
fingersticks:	O
insulin	O
dose	O
may	O
need	O
to	O
be	O
decreased	O
if	O
his	O
oral	O
intake	O
declines.	O
-	O
Please	O
keep	O
patient	O
on	O
a	O
potassium	O
restricted	O
diet	O
-	O
Please	O
note	O
that	O
on	O
CT	O
scans,	O
patient	O
noted	O
to	O
have	O
a	O
porcelain	O
gallbladder;	O
would	O
recommend	O
f/u	O
due	O
to	O
cancer	O
risk.	O
Also	O
noted	O
to	O
have	O
a	O
pericardial	O
effusion;	O
no	O
clinical	O
signs	O
of	O
tamponade.	O
-	O
Goals	O
of	O
care	O
discussion	O
was	O
held	O
with	O
wife	O
as	O
patient	O
was	O
not	O
taking	O
in	O
enough	O
fluid	O
to	O
maintain	O
a	O
normal	O
sodium	O
balance.	O
Although	O
the	O
patient	O
was	O
considered	O
safest	O
on	O
nectar	O
thick	O
liquids,	O
his	O
wife	O
agreed	O
to	O
thin	O
liquids	O
to	O
maintain	O
comfort.	O
A	O
feeding	O
tube	O
is	O
not	O
within	O
his	O
goals.	O
Dialysis	O
is	O
also	O
not	O
within	O
his	O
goals.	O
She	O
decided	O
that	O
checking	O
electrolytes	O
at	O
home	O
was	O
also	O
not	O
within	O
his	O
goals	O
as	O
it	O
might	O
prompt	O
a	O
hospital	O
admission.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Creon	O
12	O
3	O
CAP	O
PO	O
BID	O
2.	O
Doxazosin	O
8	O
mg	O
PO	O
HS	O
3.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
5.	O
Azathioprine	O
50	O
mg	O
PO	O
DAILY	O
6.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
TID	O
7.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
8.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
BID	O
9.	O
PredniSONE	O
5	O
mg	O
PO	O
QAM	O
10.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
11.	O
Tacrolimus	O
2	O
mg	O
PO	O
Q12H	O
12.	O
Epoetin	O
Alfa	O
4000	O
units	O
SC	O
WEEKLY	O
13.	O
TraMADOL	O
(Ultram)	O
50	O
mg	O
PO	O
Q6H:PRN	O
pain	O
14.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
/	O
fever	O
15.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
constipation	B-Constipation
16.	O
Sertraline	O
100	O
mg	O
PO	O
DAILY	O
17.	O
HydrALAzine	O
75	O
mg	O
PO	O
Q8H	O
18.	O
Glargine	O
10	O
Units	O
Breakfast	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
/	O
fever	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
constipation	B-Constipation
RX	O
*bisacodyl	O
10	O
mg	O
1	O
suppository(s)	O
rectally	O
every	O
night	O
Disp	O
#*15	O
Suppository	O
Refills:*0	O
4.	O
Doxazosin	O
8	O
mg	O
PO	O
HS	O
5.	O
HydrALAzine	O
75	O
mg	O
PO	O
Q8H	O
RX	O
*hydralazine	O
50	O
mg	O
1.5	O
tablet(s)	O
by	O
mouth	O
every	O
8	O
hours	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
6.	O
PredniSONE	O
5	O
mg	O
PO	O
QAM	O
7.	O
Creon	O
12	O
3	O
CAP	O
PO	O
BID	O
RX	O
*lipase-protease-amylase	O
[Creon]	O
12,000	O
unit-38,000	O
unit-60,000	O
unit	O
3	O
capsule(s)	O
by	O
mouth	O
twice	O
daily	O
Disp	O
#*180	O
Capsule	O
Refills:*0	O
8.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
TID	O
RX	O
*calcium	O
carbonate	O
500	O
mg	O
calcium	O
(1,250	O
mg)	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
daily	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
9.	O
Epoetin	O
Alfa	O
4000	O
units	O
SC	O
WEEKLY	O
RX	O
*epoetin	O
alfa	O
[Procrit]	O
4,000	O
unit/mL	O
4000	O
U	O
Inj	O
weekly	O
Disp	O
#*1	O
Vial	O
Refills:*0	O
10.	O
Labetalol	O
200	O
mg	O
PO	O
BID	O
RX	O
*labetalol	O
200	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
daily	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
11.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
RX	O
*B	O
complex	O
with	O
C#20-folic	O
acid	O
[Renal	O
Caps]	O
1	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
12.	O
Sodium	O
Bicarbonate	O
650	O
mg	O
PO	O
TID	O
RX	O
*sodium	O
bicarbonate	O
650	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
daily	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
13.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
RX	O
*amlodipine	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
14.	O
Glargine	O
12	O
Units	O
Breakfast	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
RX	O
*insulin	O
glargine	O
[Lantus	O
Solostar]	O
100	O
unit/mL	O
(3	O
mL)	O
12	O
U	O
SC	O
12	O
Units	O
before	O
BKFT;	O
Disp	O
#*5	O
Syringe	O
Refills:*0	O
RX	O
*insulin	O
lispro	O
[Humalog]	O
100	O
unit/mL	O
___	O
U	O
SC	O
Up	O
to	O
11	O
Units	O
QID	O
per	O
sliding	O
scale	O
Disp	O
#*2	O
Vial	O
Refills:*0	O
15.	O
Tacrolimus	O
2	O
mg	O
PO	O
Q12H	O
16.	O
Sertraline	O
100	O
mg	O
PO	O
DAILY	O
RX	O
*sertraline	O
100	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	B-Lives_alone
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
Influenza,	O
___	O
Tract	O
Infection,	O
Diabetic	O
Ketoacidosis,	O
Acute	O
on	O
Chronic	O
Kidney	O
Disease,	O
Hyperkalemia	O
SECONDARY:	O
Renal	O
Transplant	O
Status,	O
Type	O
I	O
Diabetes	O
Mellitus	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
transferred	O
to	O
___	O
from	O
___	O
after	O
presenting	O
to	O
there	O
from	O
your	O
rehab	O
facility	O
with	O
fever,	O
fatigue,	O
confusion,	B-Delirium
and	O
weakness.	O
You	O
were	O
found	O
to	O
have	O
the	O
flu	O
and	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
(UTI).	B-Urinary_tract_infection
Because	O
of	O
the	O
illness,	O
they	O
caused	O
your	O
blood	O
sugar	O
level	O
to	O
become	O
really	O
high	O
and	O
exacerbated	O
your	O
diabetes.	O
We	O
treated	O
in	O
the	O
intensive	O
care	O
unit	O
(ICU)	O
initially	O
with	O
broad	O
antibiotics	O
and	O
flu	O
medication.	O
Your	O
kidney	O
was	O
found	O
to	O
be	O
damaged,	O
but	O
it	O
improved	O
after	O
we	O
gave	O
you	O
IV	O
fluids.	O
You	O
were	O
shortly	O
transferred	O
out	O
of	O
the	O
ICU	O
to	O
the	O
regular	O
medical	O
floor,	O
where	O
we	O
continued	O
your	O
flu	O
medication.	O
Your	O
flu	O
symptoms	O
improved	O
quickly.	O
We	O
eventually	O
found	O
that	O
your	O
UTI	B-Urinary_tract_infection
was	O
due	O
to	O
a	O
yeast,	O
and	O
we	O
switched	O
you	O
from	O
antibiotics	O
to	O
an	O
antifungal	O
medication.	O
We	O
had	O
to	O
adjust	O
your	O
immunesuppression	O
regimen	O
due	O
to	O
elevated	O
levels	O
of	O
tacrolimus	O
and	O
drug	O
interactions.	O
Last,	O
we	O
stopped	O
your	O
azathioprine	O
out	O
of	O
concern	O
that	O
it	O
may	O
have	O
contributed	O
to	O
low	O
blood	O
cell	O
counts,	O
which	O
you	O
will	O
need	O
to	O
get	O
monitored	O
as	O
an	O
outpatient.	O
We	O
also	O
found	O
that	O
you	O
had	O
an	O
infection	O
with	O
a	O
virus	O
called	O
EBV.	O
Your	O
transplant	O
team	O
is	O
aware	O
and	O
will	O
monitor	O
your	O
immunosuppression	O
to	O
prevent	O
this	O
infection	O
from	O
worsening.	O
After	O
discussions	O
with	O
your	O
family,	O
it	O
was	O
determined	O
that	O
home	B-Lives_alone
hospice	O
care	O
would	O
best	O
fit	O
your	O
needs.	O
We	O
have	O
arranged	O
for	O
you	O
to	O
return	O
home	B-Lives_alone
with	O
hospice	O
services.	O
Please	O
take	O
your	O
medications	O
as	O
directed	O
and	O
keep	O
all	O
of	O
your	O
doctorÂ’s	O
appointments.	O
It	O
was	O
a	O
pleasure	O
to	O
take	O
care	O
of	O
you	O
during	O
your	O
hospitalization.	O
___	O
hesitate	O
to	O
contact	O
us	O
with	O
any	O
questions	O
or	O
concerns.	O
Sincerely,	O
Your	O
___	O
Medicine	O
Team	O
Followup	O
Instructions:	O
___	O

